Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants
PHASE1This study with ALTB-268 will determine the safety, tolerability, pharmacok...
Status
Active Not Recruiting
Location
Syneos Health Clinical Research Services, LLC
Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics
PHASE2ALTB-268-201 is a Phase 2a, multicenter, single arm, multiple-dose, open-la...
Status
Active Not Recruiting
Location
San Diego Gastroenterology
A First-In-Human SAD and MAD Study to Evaluate the Safety, Tolerability, PK and PD of SC Administered ALTB-268 in Healthy Volunteers
PHASE1This study with ALTB-268 will determine the safety, tolerability, pharmacok...
Location
ICON Early Development Services